Journal of Medicinal Chemistry · 2002 · 35 citations · 5 references
Natural SciencesChemistryPharmacologyNuclear ChemistryOrganometallic ChemistrySynthetic Medicinal ChemistryAmino Acid ChemistryRadionuclide Therapy PrinciplesBoron ChemistryHydrophobic BondingNeutron Capture ProcessesNeutron-capture Reactions
New boron-containing polyamine have been synthesized: (aminoalkylamine)-N-(aminoalkyl)azanonaborane(11) derivatives [H(2)N(CH(2))(n)H(2)NB(8)H(11)NH(CH(2))(n)NH(2)], where n = 4-6 and 12, and [H(2)N(CH(2))(3)H(2)NB(8)H(11)NH(CH(2))(4)NH(2)]. (4-Aminobutylamine)-N-(4-aminobutyl)azanonaborane and (3-aminopropylamine)-N-(4-aminobutyl)azanonaborane were less toxic in vitro (LD(50) of approximately 700 and approximately 1100 microM, respectively) than spermine, while (4-aminobutylamine)-N-isopropylazanonaborane with its hydrophobic isopropyl group and those with n = 5, 6, and 12 were already toxic under similar conditions (LD(50) << 500 microM). These compounds may be useful as delivery agents for boron neutron capture therapy.
5
A HISTORY OF BORON NEUTRON CAPTURE THERAPY OF BRAIN TUMOURS
D. N. Slatkin · Brain · 1991 · 202 citations
Medicine, Oncology, Toxicology +14
Synthetic polyamine analogs as antineoplastics
Raymond J. Bergeron, Allen H. Neims, James S. McManis et al. · Journal of Medicinal Chemistry · 1988 · 186 citations
An examination of O-2-isocephems as orally absorbable antibiotics
Harold Mastalerz, Marcel Ménard, Vivianne Vinet et al. · Journal of Medicinal Chemistry · 1988 · 48 citations